Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Prostate|April 3, 2018
Role of serum response factor expression in prostate cancer biochemical recurrenceMaria Prencipe, Aurelie Fabre, Thomas Brendan Murphy, et al.
Neonatology|June 15, 2023
Melatonin Alters Innate Immune Function in Infants with Neonatal EncephalopathySaima Aslam, Mary O'Dea, Lynne A Kelly, et al.
BJUI Compass|January 29, 2025
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancerAgnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, et al.
European Urology Focus|April 27, 2023
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate CancerAgnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, et al.
Cancers|August 27, 2021
Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical ProstatectomyShirin Moghaddam, Amirhossein Jalali, Amanda O'Neill, et al.
Nature Genetics|September 11, 2024
Disease prediction with multi-omics and biomarkers empowers case-control genetic discoveries in the UK BiobankManik Garg, Marcin Karpinski, Dorota Matelska, et al.
The Prostate|July 21, 2017
Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgeryKieran J Breen, Amanda O'Neill, Lisa Murphy, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 19, 2023
Selective modulation of monocyte and neutrophil responses with activated protein C in preterm infantsHassan O Eliwan, William R G Watson, Ashanty M Melo, et al.
Nature|February 4, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomesXueqing Zoe Zou, Fengyuan Hu, Haiyi Lou, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 5